Schwaiger M - Search Results

1

Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.

Dose-Schwarz J, Tiling R, Avril-Sassen S, Mahner S, Lebeau A, Weber C, Schwaiger M, Jänicke F, Untch M, Avril N. Dose-Schwarz J, et al. Among authors: schwaiger m. Br J Cancer. 2010 Jan 5;102(1):35-41. doi: 10.1038/sj.bjc.6605427. Epub 2009 Nov 17. Br J Cancer. 2010. PMID: 19920815 Free PMC article. Clinical Trial.

2

Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Avril N, Dose J, Jänicke F, Ziegler S, Römer W, Weber W, Herz M, Nathrath W, Graeff H, Schwaiger M. Avril N, et al. Among authors: schwaiger m. J Natl Cancer Inst. 1996 Sep 4;88(17):1204-9. doi: 10.1093/jnci/88.17.1204. J Natl Cancer Inst. 1996. PMID: 8780629

3

Breast imaging with fluorine-18-FDG PET: quantitative image analysis.

Avril N, Bense S, Ziegler SI, Dose J, Weber W, Laubenbacher C, Römer W, Jänicke F, Schwaiger M. Avril N, et al. Among authors: schwaiger m. J Nucl Med. 1997 Aug;38(8):1186-91. J Nucl Med. 1997. PMID: 9255146 Free article.

4

FDG PET evaluation of granular cell tumor of the breast.

Hoess C, Freitag K, Kolben M, Allgayer B, Laemmer-Skarke I, Nathrath WB, Avril N, Roemer W, Schwaiger M, Graeff H. Hoess C, et al. Among authors: schwaiger m. J Nucl Med. 1998 Aug;39(8):1398-401. J Nucl Med. 1998. PMID: 9708516 Free article.

5

Relevance of positron emission tomography (PET) in oncology.

Weber WA, Avril N, Schwaiger M. Weber WA, et al. Among authors: schwaiger m. Strahlenther Onkol. 1999 Aug;175(8):356-73. doi: 10.1007/s000660050022. Strahlenther Onkol. 1999. PMID: 10481766 Review.

6

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer.

Schelling M, Avril N, Nährig J, Kuhn W, Römer W, Sattler D, Werner M, Dose J, Jänicke F, Graeff H, Schwaiger M. Schelling M, et al. Among authors: schwaiger m. J Clin Oncol. 2000 Apr;18(8):1689-95. doi: 10.1200/JCO.2000.18.8.1689. J Clin Oncol. 2000. PMID: 10764429

7

Quantitative assessment of tumor metabolism using FDG-PET imaging.

Weber WA, Schwaiger M, Avril N. Weber WA, et al. Among authors: schwaiger m. Nucl Med Biol. 2000 Oct;27(7):683-7. doi: 10.1016/s0969-8051(00)00141-4. Nucl Med Biol. 2000. PMID: 11091112 Review.

8

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

Avril N, Menzel M, Dose J, Schelling M, Weber W, Jänicke F, Nathrath W, Schwaiger M. Avril N, et al. Among authors: schwaiger m. J Nucl Med. 2001 Jan;42(1):9-16. J Nucl Med. 2001. PMID: 11197987 Free article.

9

Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose.

Avril N, Dose J, Jänicke F, Bense S, Ziegler S, Laubenbacher C, Römer W, Pache H, Herz M, Allgayer B, Nathrath W, Graeff H, Schwaiger M. Avril N, et al. Among authors: schwaiger m. J Clin Oncol. 1996 Jun;14(6):1848-57. doi: 10.1200/JCO.1996.14.6.1848. J Clin Oncol. 1996. PMID: 8656253

10

Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.

Avril N, Rosé CA, Schelling M, Dose J, Kuhn W, Bense S, Weber W, Ziegler S, Graeff H, Schwaiger M. Avril N, et al. Among authors: schwaiger m. J Clin Oncol. 2000 Oct 15;18(20):3495-502. doi: 10.1200/JCO.2000.18.20.3495. J Clin Oncol. 2000. PMID: 11032590 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,085 results

Search Page

Filters